TipRanks on MSN
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
Kissei Pharmaceutical Co (($KSPHF)) announced an update on their ongoing clinical study. Study Overview: Kissei Pharmaceutical Co. is conducting a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback